FDA Person
FDASamson O. Oluseye
View detailed information about Samson O. Oluseye, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 49 inspections of 47 companies, 2023–2026.
Inspections (49)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 3, 2026 | Botanix SB Inc. | Not classified | #1335716 | |
| August 27, 2026 | Motiva USA, LLC | Not classified | Project Evaluation: Devices | #1333538 |
| July 20, 2026 | Capricor, Inc. | Not classified | Human Cellular, Tissue, and Gene Therapies | #1328588 |
| June 9, 2026 | Billy Hour, M.D. | Not classified | Bioresearch Monitoring | #1322464 |
| April 21, 2026 | Bard Peripheral Vascular Inc | Not classified | #1313830 | |
| March 31, 2026 | SYNAPTIC MEDICAL CORPORATION | Not classified | Product Evaluation: Medical Devices | #1310240 |
| March 12, 2026 | Imaging Endpoints II, LLC. | Not classified | #1309166 | |
| February 6, 2026 | Zhimin Shao | NAI | Bioresearch Monitoring | #1304796 |
| January 16, 2026 | David M. Scarpino, M.D. | Not classified | Bioresearch Monitoring: Human Drugs | #1298792 |
| November 7, 2025 | Amphastar Pharmaceuticals, Inc. | Not classified | #1290538 | |
| September 24, 2025 | Keith A. Marcus, M.D. | Not classified | #1285786 | |
| June 27, 2025 | KURA ONCOLOGY INC | NAI | Bioresearch Monitoring | #1276133 |
| June 6, 2025 | PharmaLegacy Research LLC | Not classified | Bioresearch Monitoring: Human Drugs | #1271917 |
| May 16, 2025 | Philisiwe B. Makhoba, M.D. | NAI | Bioresearch Monitoring | #1271912 |
| May 9, 2025 | Khatija Ahmed, M.D. | NAI | Bioresearch Monitoring | #1271800 |
| April 3, 2025 | Amphastar Pharmaceuticals, Inc. | NAI | Bioresearch Monitoring | #1266798 |
| March 21, 2025 | Charles River Laboratories, Inc. | VAI | Bioresearch Monitoring: Human Drugs | #1264587 |
| January 10, 2025 | Prodrome Sciences USA, LLC | OAI | Bioresearch Monitoring: Human Drugs | #1258362 |
| January 10, 2025 | Prodrome Sciences USA, LLC | OAI | Bioresearch Monitoring | #1258362 |
| November 20, 2024 | Center for Immunology Science, LLC | OAI | Bioresearch Monitoring: Human Drugs | #1254663 |
Documents (16)
- 483 · PharmaLegacy Research LLC · June 6, 2025
- 483 · Amphastar Pharmaceuticals, Inc. · November 7, 2025
- 483 · David M. Scarpino, M.D. · January 16, 2026
- 483 · Prodrome Sciences USA, LLC · January 10, 2025
- 483 · Charles River Laboratories, Inc. · March 21, 2025
- 483 · Charles River Laboratories, Inc. DBA Charles River, Endosafe · March 21, 2025
- 483 · Michael E. Gottschalk, M.D. · August 5, 2022
- 483 · Nobles Medical Technology, II · October 20, 2023
- 483 · Shireen V. Guide, M.D. · October 7, 2022
- 483 · Pomona Valley Hospital Medical Center IRB #1 · June 28, 2023
- 483 · Amitabha Mazumder, M.D. · April 5, 2024
- 483 · Rafaelito S. Victoria, MD · June 10, 2022
- 483 · Michael Chung, M.D. · November 13, 2023
- 483 · SYNAPTIC MEDICAL CORPORATION · March 31, 2026
- 483 · Inhibrx Biosciences Inc. · July 2, 2026
- 483 · Capricor, Inc. · July 20, 2026
Frequently inspected with (10)
Person Information
Name
Samson O. Oluseye
Role
ISSUING OFFICER
ID: bfe102f5-25cb-4ed9-9e69-2ec5ec0a047f
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.